Last reviewed · How we verify
NCT05678049
Evaluation and Characterisation of Microplastics and Nanoplastics in Joint Synovial Liquid
trial testing Synovial fluid analysis in Osteoarthritis, Knee in 50 participants. Status unknown.
15 December 2023
Quick facts
| Lead sponsor | Iuliu Hatieganu University of Medicine and Pharmacy |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 50 |
| Start date | 15 January 2023 |
| Primary completion | 15 December 2023 |
| Estimated completion | 15 December 2024 |
Drugs / interventions tested
- Synovial fluid analysis
Conditions studied
- Osteoarthritis, Knee — all drugs for Osteoarthritis, Knee →
- Knee Arthritis — all drugs for Knee Arthritis →
- Gout Arthritis — all drugs for Gout Arthritis →
- Microcrystal Disease — all drugs for Microcrystal Disease →
Sponsor
Iuliu Hatieganu University of Medicine and Pharmacy
Who can join
Adults 18 to 90, any sex, with Osteoarthritis, Knee or Knee Arthritis. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The research study aims to evaluate the synovial fluid to highlight the presence of possible micropolymers (micro/nanoplastics) in order to better understand the pathophysiology of joint degenerative processes. For patients with liquid under tension at the joint level, the symptomatology often requires evacuation by puncture under ultrasound guidance. The intervention will be performed only for patients for whom this therapeutic indication exists anyway by their physician. The investigators want to use this liquid for Microscopic and Spectrophotometric evaluation.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05678049
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Osteoarthritis, Knee
Currently open trials in the same condition.
- NCT07509307 — AMAZE 6: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee · Phase 3 · recruiting
- NCT06488144 — Rehabilitation for Arthritis of The Knee: mainTaining Improvement for Veterans · Phase 3 · recruiting
- NCT07386561 — Virtual Reality Therapy and Non-Sleep Deep Rest Relaxation After Joint Arthroplasty · NA · active not recruiting
- NCT07514598 — Effect of J-Shaped Incision After Total Knee Arthroplasty (J-TKA) · NA · active not recruiting
- NCT07058623 — Nurse-Led Telehealth vs In-Person Follow-Up After Total Knee Replacement · NA · recruiting
Other Iuliu Hatieganu University of Medicine and Pharmacy trials
Trials by the same sponsor.
- NCT07397091 — Using Routine Inflammatory and Metabolic Blood Tests (Bedside Included) to Predict Brain Injury in Children After Minor · not yet recruiting
- NCT07362173 — Actualities in Procedural Sedation: Remimazolam · Phase 4 · active not recruiting
- NCT06771999 — Attitudes Towards Deprescribing Medications in Cancer Patients and Impact of Educational Intervention by a Clinical Phar · NA · recruiting
- NCT06251869 — Electrocoagulation vs. Cold Knife Cutting in Joint Arthroplasty (Electrocoagulation vs Scalpel) · recruiting
- NCT06283836 — Dexmedetomidine vs. Remifentanil Conscious Sedation for Stapedotomy/Stapedectomy · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05678049 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Iuliu Hatieganu University of Medicine and Pharmacy
- Last refreshed: 10 January 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05678049.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing